Angelo Auricchio, and Frits W. Prinzen JACEP 2017;j.jacep

Slides:

Advertisements

Similar presentations

Presenter Disclosure Information

Advertisements

Cardiovascular Disaster in Hemodialysis patients

The Importance of Beta-Blockers in Patients with Heart Failure: A Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT) Analysis.

Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy.

Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010 CRT: vi.

Sudden Cardiac Death in Heart Failure Trial Presented at American College of Cardiology Scientific Sessions 2004 Presented by Dr. Gust H. Bardy SCD-HeFTSCD-HeFT.

May 2005 EP Show The EP Show COMPANION and CARE-HF Eric Prystowsky MD Director, Clinical Electrophysiology Laboratory St Vincent Hospital Indianapolis,

Target Study Cardiac resynchronization therapy (CRT) is an established treatment for advanced heart failure symptoms, impaired LV systolic function, and.

Cardiac Resynchronization Therapy (CRT) Is an Effective Treatment for Heart Failure and Indications Are Expanding Multiple trials have shown the clinical.

Dr Eric Prystowsky Director Clinical Electrophysiology Laboratory St Vincent Hospital, Indianapolis Dr Leslie Saxon Chief, Electrophysiology Laboratory.

Date of download: 6/26/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Impact of QRS Duration on Clinical Event Reduction.

Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Clinical Effectiveness of CRT and ICD Therapy in.

Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Effect of Intermittent Atrial Tachyarrhythmia.

A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart.

Fig ACCF/AHA Guideline for the management of heart failure

Copyright © 2011 American Medical Association. All rights reserved.

BLOCK HF Study Biventricular versus Right Ventricular Pacing in Patients with Left Ventricular Dysfunction and Atrioventricular Block – Preliminary Results.

Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotensinconvertingenzyme; ARB, angiotensin receptor blocker; CRT-D,

Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator:

Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotens inconverting enzyme; ARB, angiotensin receptor blocker;

– р<0.05 between baseline

Circ Arrhythm Electrophysiol

Figure 1 Study flow chart.

Kuznetsov VA, Soldatova AM, Krinochkin DV, Enina TN

Cardiac Resynchronization Therapy Using Quadripolar Versus Non‐Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single‐Site Left.

2) Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114

Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Implementation Ratika Parkash, MD, MSc, François Philippon,

Volume 13, Issue 1, Pages (January 2016)

Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Evidence and Patient Selection Derek V. Exner, MD, MPH, David.

Clyde W. Yancy et al. JACC 2017;70:

Erratum Heart Rhythm Volume 8, Issue 4, (April 2011)

Ragavendra R. Baliga, MD, MBA Heart Failure Clinics

José L. Morales et al. JACEP 2017;j.jacep

INOVATE-HF Trial design: Patients with heart failure (HF) were randomized to device implant for vagus nerve stimulation (n = 436) versus optimal medical.

Volume 14, Issue 9, Pages (September 2017)

Shadi Al Halabi et al. JACEP 2015;1:

Volume 9, Issue 8, Pages S3-S13 (August 2012)

Gaurav A. Upadhyay, MD, Jonathan S. Steinberg, MD Heart Rhythm

David D. Berg et al. JACC 2018;71:

Mirnela Byku, and Douglas L. Mann BTS 2016;1:95-106

Angelo Auricchio, and Frits W. Prinzen JACEP 2017;3:

Mirnela Byku, and Douglas L. Mann BTS 2016;1:95-106

David F. Katz et al. JACEP 2016;j.jacep

Mintu P. Turakhia et al. JACEP 2016;2:

Mahesh Anantha Narayanan et al. JACEP 2017;3:

Prabhat Kumar et al. JACEP 2016;j.jacep

Ethnic and racial disparities in cardiac resynchronization therapy

Jonathan M. Behar et al. JACEP 2017;3:

Volume 13, Issue 8, Pages (August 2016)

Mintu P. Turakhia et al. JACEP 2016;2:

Outcomes After Ventricular Fibrillation Out-of-Hospital Cardiac Arrest: Expanding the Chain of Survival T. Jared Bunch, MD, Stephen C. Hammill, MD, Roger.

Angelo Auricchio, and Frits W. Prinzen JACEP 2017;3:

Volume 15, Issue 1, Pages (January 2018)

Shannon M. Dunlay, MD, MS, Naveen L. Pereira, MD, Sudhir S

CHAMPION Trial design: Patients with recent hospitalization for heart failure were implanted with a pulmonary artery pressure monitor and randomized so.

Prabhat Kumar et al. JACEP 2016;j.jacep

Angelo Auricchio, and Frits W. Prinzen JACEP 2017;3:

Understanding the cardiac substrate and the underlying physiology: Implications for individualized treatment algorithm John Gorcsan, MD, Frits W. Prinzen,

Volume 7, Issue 7, Pages (July 2010)

David F. Katz et al. JACEP 2017;3:20-28

Volume 12, Issue 10, Pages (October 2015)

Mintu P. Turakhia et al. JACEP 2016;2:

Emilce Trucco et al. JACEP 2018;j.jacep

Mahesh Anantha Narayanan et al. JACEP 2017;j.jacep

Figure 1 Cumulative late adjusted survival in cardiac resynchronization therapy defibrillator and pacemaker patients. ... Figure 1 Cumulative late adjusted.

Jordan S. Leyton-Mange et al. JACEP 2017;j.jacep

Saadia Sherazi et al. JACEP 2015;1:74-80

Results of comparisons of treatments in the network.

Rick A. Nishimura et al. JACC 2017;70:

Jeffrey Senfield et al. JACEP 2017;3:

Presentation transcript:

Angelo Auricchio, and Frits W. Prinzen JACEP 2017;j.jacep.2017.08.005 Compilation of the Various Effects of CRT (A) Acute hemodynamic effect as reported by the PATH-CHF study (adapted from Auricchio A. et al.; [5]). (B) Reverse remodeling as described in REVERSE study (adapted from Linde C. et al.; [6]). (C) Reduction in hospitalization for heart failure as shown by MADIT-CRT (adapted from Moss A et al. NEJM 2014; [7]). (D) Reduction in mortality as reported by the RAFT trial (adapted from Tang et al. NEJM 2014; [8]). CRT = cardiac resynchronization therapy; CI = confidence interval; ICD = implanted cardioverter-defibrillator; LV dP/dtmax = first derivative of left ventricular pressure; LVESVi = left ventricular end-systolic volume index. Angelo Auricchio, and Frits W. Prinzen JACEP 2017;j.jacep.2017.08.005 2017 The Authors